139 related articles for article (PubMed ID: 20340055)
81. Prognostic significance of tissue polypeptide antigen (TPA) in head and neck carcinomas.
Becciolini A; Porciani S; Lanini A; Tommasi M; Olmi P; Chiavacci A
Acta Oncol; 1993; 32(3):295-9. PubMed ID: 8323767
[TBL] [Abstract][Full Text] [Related]
82. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
83. Inverse immunological responses induced by allergic rhinitis and head and neck squamous cell carcinoma.
Millrud CR; Hylander T; Kumlien Georen S; Kågedal Å; Winqvist O; Cardell LO
PLoS One; 2014; 9(1):e86796. PubMed ID: 24466243
[TBL] [Abstract][Full Text] [Related]
84. Serum and tissue metabolomics of head and neck cancer.
Yonezawa K; Nishiumi S; Kitamoto-Matsuda J; Fujita T; Morimoto K; Yamashita D; Saito M; Otsuki N; Irino Y; Shinohara M; Yoshida M; Nibu K
Cancer Genomics Proteomics; 2013; 10(5):233-8. PubMed ID: 24136976
[TBL] [Abstract][Full Text] [Related]
85. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.
Lathers DM; Young MR
Cytokine; 2004 Mar; 25(5):220-8. PubMed ID: 15036248
[TBL] [Abstract][Full Text] [Related]
86. Association of a alpha1 acidic glycoprotein and squamous cell carcinoma of the head and neck.
Croce MV; Price MR; Segal-Eiras A
Pathol Oncol Res; 2001; 7(2):111-7. PubMed ID: 11458273
[TBL] [Abstract][Full Text] [Related]
87. Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India.
Choudhury B; Srivastava S; Choudhury HH; Purkayastha A; DuttaGupta S; Ghosh SK
Tumour Biol; 2014 Jul; 35(7):6739-48. PubMed ID: 24715304
[TBL] [Abstract][Full Text] [Related]
88. Assessment of p38α in peripheral blood mononuclear cells (PBMC): a potential blood protein marker of head and neck squamous cell carcinoma.
Gill K; Kumar R; Mohanti BK; Dey S
Clin Transl Oncol; 2013 Nov; 15(11):969-73. PubMed ID: 23553334
[TBL] [Abstract][Full Text] [Related]
89. Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck.
Walker DD; Reeves TD; de Costa AM; Schuyler C; Young MR
Cytokine; 2012 Jun; 58(3):448-54. PubMed ID: 22450225
[TBL] [Abstract][Full Text] [Related]
90. Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study.
Aderhold C; Grobschmidt GM; Sauter A; Faber A; Hörmann K; Schultz JD
Oncol Lett; 2014 Sep; 8(3):1112-1118. PubMed ID: 25120668
[TBL] [Abstract][Full Text] [Related]
91. Nanostructured immunosensor for attomolar detection of cancer biomarker interleukin-8 using massively labeled superparamagnetic particles.
Munge BS; Coffey AL; Doucette JM; Somba BK; Malhotra R; Patel V; Gutkind JS; Rusling JF
Angew Chem Int Ed Engl; 2011 Aug; 50(34):7915-8. PubMed ID: 21721091
[No Abstract] [Full Text] [Related]
92. Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem.
Falco M; Tammaro C; Takeuchi T; Cossu AM; Scafuro G; Zappavigna S; Itro A; Addeo R; Scrima M; Lombardi A; Ricciardiello F; Irace C; Caraglia M; Misso G
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406495
[TBL] [Abstract][Full Text] [Related]
93. Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction.
Meyer TJ; Stöth M; Moratin H; Ickrath P; Herrmann M; Kleinsasser N; Hagen R; Hackenberg S; Scherzad A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922946
[TBL] [Abstract][Full Text] [Related]
94. Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review.
Uz U; Eskiizmir G
Clin Exp Otorhinolaryngol; 2021 Feb; 14(1):50-60. PubMed ID: 33587847
[TBL] [Abstract][Full Text] [Related]
95. Correlations between serum cetuximab and EGFR-related markers, and skin disorders in head and neck cancer patients.
Shibata K; Naito T; Hirakawa S; Suzuki K; Hosokawa S; Mineta H; Kawakami J
Cancer Chemother Pharmacol; 2021 Apr; 87(4):555-565. PubMed ID: 33462734
[TBL] [Abstract][Full Text] [Related]
96. IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells.
Li Y; Chen G; Han Z; Cheng H; Qiao L; Li Y
Onco Targets Ther; 2020; 13():9721-9730. PubMed ID: 33061451
[TBL] [Abstract][Full Text] [Related]
97. Serum CXCL12, but not CXCR4, Is Associated with Head and Neck Squamous Cell Carcinomas.
Lavaee F; Zare S; Mojtahedi Z; Malekzadeh M; Khademi B; Ghaderi A
Asian Pac J Cancer Prev; 2018 Apr; 19(4):901-904. PubMed ID: 29693336
[TBL] [Abstract][Full Text] [Related]
98. Interleukin-6 role in head and neck squamous cell carcinoma progression.
Choudhary MM; France TJ; Teknos TN; Kumar P
World J Otorhinolaryngol Head Neck Surg; 2016 Jun; 2(2):90-97. PubMed ID: 29204553
[TBL] [Abstract][Full Text] [Related]
99. Bazedoxifene enhances the anti-tumor effects of cisplatin and radiation treatment by blocking IL-6 signaling in head and neck cancer.
Yadav A; Kumar B; Teknos TN; Kumar P
Oncotarget; 2017 Sep; 8(40):66912-66924. PubMed ID: 28978005
[TBL] [Abstract][Full Text] [Related]
100. IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer.
Stabile LP; Egloff AM; Gibson MK; Gooding WE; Ohr J; Zhou P; Rothenberger NJ; Wang L; Geiger JL; Flaherty JT; Grandis JR; Bauman JE
Oral Oncol; 2017 Jun; 69():38-45. PubMed ID: 28559019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
